Krystal Biotech to Present at 8th Annual Evercore Healthcare Conference

Krystal Biotech (NASDAQ: KRYS) will participate in the 8th Annual Evercore Healthcare Conference on December 3, 2025 in Miami.

Rhea-AI Summary

Krystal Biotech (NASDAQ: KRYS) will participate in the 8th Annual Evercore Healthcare Conference on December 3, 2025 in Miami.

Krish S. Krishnan, Chairman and CEO, will appear in a fireside chat at 10:00 am ET and will host investor meetings throughout the day. A webcast of the presentation will be available beginning at 10:00 am ET on December 3, 2025 and will be posted in the Investors section of the company website.

Argus Nov 26 session

+0.80% close to close Open Argus

Details

News Market Reaction – KRYS

On Nov 26, the day this news came out, KRYS closed 0.80% above the previous close.

Data tracked by StockTitan Argus for the Nov 26 session.

Market Context

This announcement outlines Krystal Biotech’s participation in the Evercore Healthcare Conference on ...

Analysis

This announcement outlines Krystal Biotech’s participation in the Evercore Healthcare Conference on December 3, 2025, including a 10:00 am ET fireside chat and investor meetings. It represents standard investor-relations activity rather than a new clinical or financial milestone. In context of recent FDA label and platform wins plus strong earnings, investors may watch for any incremental commentary on commercialization trends, pipeline timelines, or capital deployment during the conference webcast.

Key Figures

Conference date: December 3, 2025 Fireside chat time: 10:00 am ET

Conference date

December 3, 2025

Evercore Healthcare Conference participation

Fireside chat time

10:00 am ET

Scheduled presentation time at conference

Historical Context

5 past events · Latest: Nov 26

5 events

1. Nov 26

   Investor conference

   24h Move

   +0.8%

   Announcement of Evercore conference appearance and webcast access details.

2. Nov 03

   Earnings results

   24h Move

   +0.2%

   Reported Q3 2025 financial and operating results with VYJUVEK revenue detail.

3. Oct 21

   Earnings scheduling

   24h Move

   -2.6%

   Set date and webcast for upcoming Q3 2025 financial results release.

4. Oct 14

   FDA designation

   24h Move

   +1.8%

   FDA granted platform technology designation for HSV-1 vector used in KB801.

5. Sep 15

   FDA approval update

   24h Move

   +8.4%

   FDA approved updated VYJUVEK label expanding eligibility and at-home use.

24h Move is the share-price change in the day after each event; other market factors may also have contributed.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

PITTSBURGH, Nov. 26, 2025 (GLOBE NEWSWIRE) -- Krystal Biotech, Inc. (the “Company”) (NASDAQ: KRYS) today announced that the Company will participate in the 8^th Annual Evercore Healthcare Conference on December 3, 2025, in Miami. Krish S. Krishnan, Chairman and Chief Executive Officer, will take part in a fireside chat scheduled at 10:00 am ET and host investor meetings throughout the day.

A webcast of the presentation will be available here beginning at 10:00 am ET on Wednesday, December 3, 2025 and will be posted on the Investors section of the Company’s website.

About Krystal Biotech, Inc.

Krystal Biotech, Inc. (NASDAQ: KRYS) is a fully integrated, commercial-stage, global biotechnology company focused on the discovery, development and commercialization of genetic medicines to treat diseases with high unmet medical needs. VYJUVEK^®, the Company’s first commercial product, is the first-ever redosable gene therapy and the first genetic medicine approved in the United States, Europe, and Japan for the treatment of dystrophic epidermolysis bullosa. The Company is rapidly advancing a robust preclinical and clinical pipeline of investigational genetic medicines in respiratory, oncology, dermatology, ophthalmology, and aesthetics. Krystal Biotech is headquartered in Pittsburgh, Pennsylvania. For more information, please visit http://www.krystalbio.com, and follow @KrystalBiotech on LinkedIn and X (formerly Twitter).

CONTACT
Investors and Media:
Stéphane Paquette
Krystal Biotech
spaquette@krystalbio.com

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

When will Krystal Biotech (KRYS) present at the Evercore Healthcare Conference?

Krystal Biotech will present on December 3, 2025 at the 8th Annual Evercore Healthcare Conference in Miami.

What time is Krystal Biotech's (KRYS) fireside chat at the Evercore conference?

The fireside chat with Krish S. Krishnan is scheduled for 10:00 am ET on December 3, 2025.

Will Krystal Biotech (KRYS) provide a webcast of its Evercore presentation?

Yes. A webcast will be available beginning at 10:00 am ET on December 3, 2025 and will be posted on the company's Investors website.

Who will represent Krystal Biotech (KRYS) at the Evercore Healthcare Conference?

Krish S. Krishnan, Chairman and Chief Executive Officer, will take part in the fireside chat and meet with investors.

Where can investors watch Krystal Biotech's (KRYS) Evercore presentation replay?

The webcast will be posted in the Investors section of Krystal Biotech's website after the presentation on December 3, 2025.